verl is a flexible, efficient and production-ready RL training library for large language models (LLMs). verl is the open-source version of HybridFlow: A Flexible and Efficient RLHF Framework paper.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

La Vista workers on Wednesday removed Nazi graffiti from a tree stump in the city's Central Park. A resident alerted the city to the graffiti at the park, 7648 Edgewood Blvd., on Tuesday.

The second-annual Peachland Graffiti takes place next weekend, bringing together retro vibes and fun while fundraising for the Peachland Classic Car Show. The event, organized by the local chamber ...

Organon & Co (Symbol: OGN) presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

CIBC Private Wealth Group LLC grew its position in Organon & Co. (NYSE:OGN – Free Report) by 24.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission.

High-tech efforts to remove “eyesore” graffiti from a prominent wall next to Newcastle’s Town Moor have been completed. Special lasers have been used to clean up the wall along Grandstand ...

April 6, 2025 – Ventura County Sheriff's Office officials report that a total of two adults and five juveniles were arrested for gang graffiti vandalism in a combined effort between the Ventura ...

Banksy is an anonymous British graffiti artist who brings political street art to walls, bridges, and buildings worldwide. Since rising to fame in the late 1990s, the artist’s witty ...

Organon acquired regulatory and commercial rights in the United States for TOFIDENCE ™, a biosimilar to ACTEMRA ®, for intravenous infusion from Biogen. TOFIDENCE, the first approved ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Organon (OGN).

Organon has acquired regulatory and commercial rights in the United States from Biogen for Tofidence, a biosimilar to Actemra for intravenous infusion. Tofidence, the first approved tocilizumab ...